You have reached the guest article limit.
Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.
Anixa Biosciences Awarded New U.S. Patent Extending Breast Cancer Vaccine IP Protection into 2040s Anixa Biosciences, a biotechnology company specializing in cancer treatment and prevention, has been... Read the full IIPLA article: https://iipla.org/news/anixa-biosciences-awarded-new-u-s-patent-extending-breast-cancer-vaccine-ip-protection-into-2040s